Health Highlights: Dec. 14, 2022
New drug might be an advance against eczema. Rocatinlimab is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condition for up to 20 weeks after treatment was stopped. Read more
Move to electric cars will save lives and billions in health care costs. Replacing vehicles powered by gas and diesel with electric ones will pay big dividends for Americans' health, a new study finds. Read more
Big U.S. genetics study is already helping participants. Called "All of Us," the study aims to eventually include at least 1 million people, in an effort to accelerate medical breakthroughs. Read more
Long COVID has taken the lives of more than 3,500 Americans. Research is revealing that the damage caused by a COVID infection poses a long-term risk to some who survive their bout with the coronavirus. Read more
Related Posts
FDA Approves Second COVID-19 Booster for Americans 50+
TUESDAY, March 29, 2022 (HealthDay News) -- The U.S. Food and Drug...
El momento de los bochornos en la menopausia podría dar pistas sobre el riesgo de Alzheimer
JUEVES, 28 de septiembre de 2023 (HealthDay News) -- Los bochornos y sudores...
FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers
WEDNESDAY, Oct. 18, 2023 (HealthDay News) -- The U.S. Food and Drug...
Combo Therapy May Prevent Cancer’s Return After Liver Surgery
MONDAY, April 24, 2023 (HealthDay News) -- A two-drug combination therapy can...